PR Newswire

The Bulletin

Men's Weekly

.

SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

Written by PR Newswire

SK bioscience Submits IND for Phase 3 Trial of 2-Dose Varicella Vaccine Reflecting Global Standard Shift

Approximately 800 children aged 12 months to 12 years in Korea and abroad, aiming for completion by 2027
Rising demand for 2-dose regimen as international standards amid projected global market growth to USD 6.3 billion by 3034
SKBS continues strategic R&D to enhance global vaccine competitiveness of its vaccine pipelines

SEONGNAM, South Korea, Se...

Professional Removalists Melbourne: Your Trusted Experts for a Smooth, Stress-Free Move

How Lawyers in Melbourne Can Resolve Disputes Without Going to Court

Multi Unit Development Builders Melbourne: Maximising Land and Investment Potential

A Complete Checklist for Hiring Reliable Home Removalists in Perth

What is the Difference between Roadside Assistance and Towing?

Don't Renew Your Roadside Assistance Cover Until You Read This!

eCommerce Site Design: Building Modern, High-Performing Online Stores for Australian Businesses

Your Reliable Partner for Every Roadside Emergency

Choosing Waterproofing Membranes for Outdoor Spaces: The Essential Attributes You Need

How Modular Content Accelerates Turnaround for Time-Sensitive Campaigns

How Litigation Lawyers in Sydney Can Help Resolve Disputes Efficiently

Revitalising Homes and Offices with Professional Carpet Cleaning Melbourne